China's Essential Drug Prices Less Severe Than Expected; Some Prices See Increases
This article was originally published in The Pink Sheet Daily
Prices for half of the drug products on the list will stay at current levels.
You may also be interested in...
China Releases New Regs To Step Up Quality Control For Essential Drugs; Second Part Of EDL Expected In November
SHANGHAI - In the latest effort to strengthen drug safety measures in China, China's State FDA issued Sept. 24 a new quality control regulation for drugs listed on the Essential Drug List. The regulation asks local FDAs to conduct at least two inspections every year of all manufacturing sites for drugs listed
BEIJING - China's powerful National Development and Reform Commission, which has a virtually unrestricted purview over setting prices for medicines that are included on the country's Essential Drug List, is in the final stages of determining caps for every item on the newly revised list
SHANGHAI - As an important part of China's $850 billion healthcare reform plan, the Essential Drug List system will bring new challenges as well as opportunities for all players in China's drug supply chain